Adaptive Biotechnologies
ADPT
#3263
Rank
C$6.50 B
Marketcap
C$40.18
Share price
-1.44%
Change (1 day)
88.86%
Change (1 year)

Market capitalization of Adaptive Biotechnologies (ADPT)

Market cap: C$6.50 Billion

As of November 2026 Adaptive Biotechnologies has a market cap of C$6.50 Billion. This makes Adaptive Biotechnologies the world's 3263th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Adaptive Biotechnologies from 2019 to 2026

End of year Market Cap

Year Marketcap Change
2026C$6.50 B90.17%
2025C$3.42 B169.03%
2024C$1.27 B35.11%
2023C$0.94 B-36.54%
2022C$1.48 B-70.62%
2021C$5.04 B-51.06%
2020C$10.31 B110.71%
2019C$4.89 B

End of Day market cap according to different sources

On Nov 19th, 2026 the market cap of Adaptive Biotechnologies was reported to be:

C$6.50 Billion
by Nasdaq info icon info icon
C$6.50 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
HCA Healthcare
HCA
C$137.73 B 2,017.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Premier
PINC
C$3.34 B-48.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Community Health Systems
CYH
C$0.32 B-95.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Select Medical Holdings
SEM
C$2.93 B-54.93%๐Ÿ‡บ๐Ÿ‡ธ USA